Comparison of the Effects of General Anesthesia and Spinal Anesthesia on Tissue Perfusion in Patients Undergoing Lower Extremity Surgery
Perf-LEX
Comparison of the Effects of Anesthesia Techniques on Tissue Perfusion in Patients Undergoing Lower Extremity Surgery With Tourniquet Use
1 other identifier
observational
60
1 country
1
Brief Summary
This prospective, single-center observational study compares the effects of general anesthesia and spinal anesthesia on tissue perfusion in patients undergoing lower extremity surgery with tourniquet use. Tissue oxygenation in the limb distal to the tourniquet is monitored noninvasively using near-infrared spectroscopy (NIRS), and perfusion loss is quantified using an area-under-the-curve (AUC) approach. The primary objective is to evaluate whether spinal anesthesia better preserves distal tissue oxygenation during tourniquet inflation compared with general anesthesia. Secondary objectives are to assess reperfusion response after tourniquet release using changes in NIRS values at 20 minutes relative to baseline, the presence of early hyperemia (rSO₂ overshoot), and the association between tourniquet duration and perfusion loss. Additional exploratory analyses evaluate selected metabolic and inflammatory markers, including pH, lactate, and potassium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2025
CompletedFirst Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedMay 28, 2026
March 1, 2026
6 months
March 11, 2026
May 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage AUC Loss During Tourniquet Inflation
Distal tissue oxygenation/perfusion loss measured by near-infrared spectroscopy (NIRS) as the percentage area-under-the-curve (AUC) loss of regional tissue oxygen saturation (rSO₂) during tourniquet inflation.
From tourniquet inflation to tourniquet deflation during surgery
Secondary Outcomes (3)
Reperfusion Response Assessed by ΔNIRS
Baseline to 20 minutes after tourniquet deflation
Early Hyperemia (rSO₂ Overshoot)
Within 5 minutes after tourniquet deflation
Association Between Tourniquet Duration and Percentage AUC Loss
Intraoperative period, during tourniquet use
Other Outcomes (1)
Metabolic and Inflammatory Markers
Perioperative period
Study Arms (2)
General Anesthesia Group
Patients undergoing lower extremity surgery under general anesthesia.
Spinal Anesthesia Group
Patients undergoing lower extremity surgery under spinal anesthesia.
Eligibility Criteria
Adults aged 18 to 65 years with ASA physical status I-II who were scheduled for elective lower extremity orthopedic surgery with tourniquet use at Prof. Dr. Cemil Taşcıoğlu City Hospital between 01 March 2025 and 30 September 2025. Eligible patients were assessed consecutively and enrolled after providing informed consent. Patients were analyzed in 2 observational cohorts according to anesthesia method used in routine clinical practice: general anesthesia and spinal anesthesia.
You may qualify if:
- Age 18 to 65 years
- Scheduled for elective lower extremity orthopedic surgery
- ASA physical status I or II
- Expected operation duration 30 to 120 minutes
- Expected tourniquet duration 30 to 90 minutes
- Informed about the anesthesia method and agreed to participate voluntarily
- No contraindication to neuraxial block
You may not qualify if:
- Refusal to participate
- History of peripheral arterial disease, diabetic neuropathy, or advanced vascular insufficiency
- Severe or uncontrolled systemic disease, including ASA III or higher
- Coagulopathy, local infection, or contraindication to spinal anesthesia
- Body mass index greater than 35 kg/m²
- Pregnancy or impaired consciousness
- Intraoperative hemodynamic instability or anticipated instability
- Need for additional intraoperative sedative or analgesic medication
- Inability to obtain adequate and reliable NIRS signal for technical reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cemil Tasciogu Research and Training Hospital
Istanbul, Sisli, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 16, 2026
Study Start
March 25, 2025
Primary Completion
September 12, 2025
Study Completion
December 25, 2025
Last Updated
May 28, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because no formal data-sharing plan was established for this thesis-based observational study, and sharing is limited by institutional and ethics requirements.